Parkinson's disease decisions — 2025

The Board denied increased ratings for various Parkinson's disease-related conditions, except for a 10 percent rating for loss of sense of smell.

The Board remands the claims for increased ratings and TDIU due to incomplete development, including failure to schedule a VA examination and provide information regarding examiner qualifications.

The Board remands the claim for an initial disability rating higher than 30 percent for Parkinson's disease to obtain relevant private medical records and a VA medical opinion.

The Board granted an effective date of August 29, 2016, for the award of service connection for Parkinsonism with balance impairment and all separately rated residual complications or disabilities.

The Board granted service connection for parkinsonism based on the Veteran's presumed exposure to herbicide agents during his military service in Vietnam.

The Board denied the Veteran's claim for service connection for Parkinson's disease, finding that there was no evidence of an in-service injury or disease and no evidence linking the condition to his military service.

The Board denied service connection for Parkinson's disease as the evidence did not show a link to service, including any exposure at Camp Lejeune.

The Board granted service connection for Parkinson's disease on a presumptive basis due to herbicide exposure, but denied an initial compensable disability rating for hypertension.

The Board granted an effective date of November 15, 2019, for the grant of service connection for left and right side conditions associated with Parkinson's disease but denied higher ratings.

The Board granted service connection for multiple myeloma, Parkinson's disease, diabetes mellitus type II (DMII), and kidney failure secondary to DMII based on in-service herbicide exposure.

The Board denied service connection for lung cancer residuals, Parkinson's disease, neuropathy in the right and left lower extremities due to herbicide exposure, as well as special monthly compensation based on aid and attendance.

The Board denied service connection for chronic fatigue syndrome but granted eligibility for specially adapted housing, and increased the rating for bilateral lower extremity peripheral arterial occlusive disease to 60 percent from August 30, 2024. Service connection was also granted for right knee ganglion cyst and bilateral knee intrasubstance degeneration of the posterior horn of the medial meniscus patellar tendinosis with subcutaneous soft tissue swelling.

The Board remands the claim for service connection for Parkinson's disease to obtain an adequate medical opinion regarding its etiology, including considering the Veteran's TERA participation.

The Board remands the claim for a neurological disability, to include Parkinson's disease, Parkinsonism, and essential tremors for an examination to determine if there is a relationship between the condition and active service.

The Board denied an earlier effective date for the award of service connection for Parkinson's disease, as there was no clear diagnosis until March 2, 2022.

The Veteran is granted a certificate of eligibility for specially adapted housing due to the loss of use of both lower extremities resulting from service-connected Parkinson's disease. The special home adaptation grant is denied as moot.

The Board granted service connection for Parkinson's disease, as due to herbicide agent exposure on a presumptive basis.

The Board remands the claims for service connection for Parkinson's disease, prostate cancer, bilateral choroidal melanoma, malignant melanoma of the back, and a respiratory disability due to outstanding evidence and duty-to-assist errors.

The Board granted service connection for Parkinson's disease based on new and relevant evidence that asserts a causal link between exposure to diesel exhaust and increased risk for neurodegenerative disease.

The Board granted service connection for ischemic heart disease (CAD) and denied service connection for essential tremors and Parkinsonism.